Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as the pharmaceutical giant remakes itself with financial windfall netted from its covid treatments.
Pfizer seeks another ‘moonshot’ with $43 billion cancer deal
Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as the pharmaceutical giant remakes itself with financial windfall netted from its covid treatments.